The Cass Review Continues To Be Severely Flawed

It’s been nearly 18 months since I first started writing about the Cass review into clinics and treatments for gender dysphoria for children in the UK. The report had an enormous impact, both at the time and even until now. It was, in many ways, the most politically significant piece of writing that has come out about transgender children.

If you’ve read my previous pieces on the review, you will know that the document itself was enormously flawed. There are clear, persistent errors that undermine the idea that it is scientifically useful, and make it a terrible basis for policy. We should not be making decisions for children on the basis of what the Cass review said.

And now, led by the fantastic Dr. Julia Moore, I’m part of a team who have published precisely these concerns — and more — in the Medical Journal of Australia. I rarely cover my own research here — most of it is, as with the vast majority of science, extremely tedious unless you’re interested in modelling death rates or diabetes incidence for some reason — but I thought that this was a good exception.

The article is called Cass Review does not guide care for trans young people. The piece…